Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer

被引:29
作者
Man, A
Pickles, T
Chi, KN
机构
[1] British Columbia Canc Agcy, Dept Radiat, Vancouver, BC V5Z 4E6, Canada
[2] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada
关键词
prostate; prostatic neoplasms; radiotherapy; risk; mongoloid race;
D O I
10.1097/01.ju.0000081423.37043.b4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We compared survival outcomes in patients of Asian descent treated with curative intent radiation therapy for prostate cancer with that in the nonAsian population in British Columbia, Canada. Materials and Methods: Since 1994, 1,872 men treated with curative intent radiotherapy for prostate cancer have been followed prospectively at our-provincial institution, where cancer care delivery is coordinated for the province of British Columbia. Patients are treated uniformly based on provincial policies and guidelines. Patients were divided into 63 Asian (3.6%) and 1,804 nonAsian (96.4%) patients by surname with Asian names checked by telephone contact. Three risk groups were defined based on pretreatment prostate specific antigen, biopsy Gleason score and clinical T staging. For the whole cohort and each risk group survival was estimated using the Kaplan-Meier method and comparisons were made between the Asian and nonAsian populations. Results: The mean age of Asian and nonAsian men was 71.5 and 71 years, respectively. Median prostate specific antigen was 11.4 and 10 ng/ml, respectively (p = 0.7). Median Gleason score was 7 for Asian patients and 6 for nonAsian patients. (p = 0.002). There were twice the percentage of Asian patients with Gleason scores 8 or greater than nonAsians (26.5% vs 13.8%, p = 0.003). More Asian patients had stage 3 or 4 disease than nonAsians (44.8% vs 34.9%, p = 0.095). A greater proportion of Asian patients were classified as being at high risk than the nonAsian population (60.3% vs 47.6%, p = 0.04). For the entire cohort, and the low, intermediate and high risk groups there were no differences in time to first failure, or cause specific or overall survival for Asian vs nonAsian men. Conclusions: A greater proportion of patients of Asian descent present with high risk prostate cancer than nonAsian patients, which could be due to intrinsic biological differences and/or differences in diagnostic patterns. Survival outcomes after radiotherapy are the same for the 2 populations.
引用
收藏
页码:901 / 904
页数:4
相关论文
共 50 条
[41]   Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics? [J].
Viani, Gustavo Arruda ;
Hamamura, Ana Carolina ;
Correa, Alexandre Ciuffi ;
de Arruda, Felipe Teles .
INTERNATIONAL BRAZ J UROL, 2019, 45 (02) :237-245
[42]   Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features [J].
Vargas, C ;
Kestin, LL ;
Weed, DW ;
Krauss, D ;
Vicini, FA ;
Martinez, AA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (03) :714-724
[43]   Initial therapy with radical prostatectomy for high risk localized prostate cancer [J].
Montie, James E. .
JOURNAL OF UROLOGY, 2006, 176 (06) :S27-S29
[44]   Salvage radiotherapy of prostate cancer recurrences after radical prostatectomy [J].
Tkachev, S. I. ;
Bulychkin, P. V. ;
Matveev, V. B. ;
Nazarenko, A. V. ;
Panov, V. O. ;
Kossov, F. A. ;
Akhverdieva, G. I. .
ONKOUROLOGIYA, 2018, 14 (01) :100-106
[45]   The Role of Radiotherapy After Radical Prostatectomy in Patients with Prostate Cancer [J].
Gandaglia, Giorgio ;
Cozzarini, Cesare ;
Mottrie, Alexandre ;
Bossi, Alberto ;
Fossati, Nicola ;
Montorsi, Francesco ;
Briganti, Alberto .
CURRENT ONCOLOGY REPORTS, 2015, 17 (12)
[46]   Impact of curative radiotherapy on the immune status of patients with localized prostate cancer [J].
Eckert, Franziska ;
Schaedle, Philipp ;
Zips, Daniel ;
Schmid-Horch, Barbara ;
Rammensee, Hans-Georg ;
Gani, Cihan ;
Gouttefangeas, Cecile .
ONCOIMMUNOLOGY, 2018, 7 (11)
[47]   Assessment of quality of life after radical radiotherapy for prostate cancer [J].
Caffo, O ;
Fellin, G ;
Graffer, U ;
Luciani, L .
BRITISH JOURNAL OF UROLOGY, 1996, 78 (04) :557-563
[48]   Hypofractionated radiotherapy recommendations for localized prostate cancer in Brasil [J].
Freitas Palhares, Daniel Moore ;
Furbino Pimentel, Leonardo Cunha ;
Castilho, Marcus Simoes ;
da Costa, Andrea Barleze ;
Reisner, Marcio Lemberg ;
Kuhnen, Felipe Quintino ;
Passaro, Anderson ;
Teixeira Leite, Elton Trigo ;
Costa Faustino, Fabio de Lima ;
Obst, Fernando Mariano ;
Barbosa Ferro Costa, Flavio Napoleao Buarque ;
Pioner, Giovani Thomaz ;
de Carvalho, Icaro Thiago ;
Fernandes da Silva, Joao Luis ;
Kokay Morikawa, Lisa Karina ;
da Rocha Zanuncio, Pedro Henrique ;
Hanriot, Rodrigo de Morais ;
Rosa, Arthur Accioly .
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (01) :7-18
[49]   Updated evidence on oncological outcomes of surgery versus external beam radiotherapy for localized prostate cancer [J].
Taguchi, Satoru ;
Shiraishi, Kenshiro ;
Fukuhara, Hiroshi .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (09) :963-969
[50]   Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer [J].
Degeling, Koen ;
Corcoran, Niall M. ;
Pereira-Salgado, Amanda ;
Hamid, Anis A. ;
Siva, Shankar ;
IJzerman, Maarten J. .
VALUE IN HEALTH, 2021, 24 (12) :1737-1745